Status:

UNKNOWN

Fecal Microbiome Transplantation (FMT) for Type 1 Diabetes

Lead Sponsor:

The Third Affiliated Hospital of Southern Medical University

Collaborating Sponsors:

Southern Medical University, China

Conditions:

Type 1 Diabetes

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

This study intends to reconstruct intestinal micro-ecology through fecal Microbiome transplantation (FMT) technology, to treat patients with type 1 diabetes, and combine intestinal Metagenomics and 16...

Detailed Description

Type 1 diabetes is an organ-specific autoimmune disease based on islet beta cell-specific destruction and absolute insulin deficiency. Studies on the pathogenesis of intestinal flora and type 1 diabet...

Eligibility Criteria

Inclusion

  • (1) Type 1 diabetes patients.
  • (2) Age between 18 and 65 years old, regardless of gender.
  • (3) No serious comorbidities.
  • (4) Accept and suitable for endoscopic catheterization (TET) and fecal transplantation (FMT).
  • (5) Can receive follow-up and follow-up examinations on time. (6) Subjects need to sign an informed consent form.

Exclusion

  • (1) Systematic application of glucocorticoids, other immunosuppressive drugs or biological immune modulators, antibiotics, probiotics, and other microecological agents to alter intestinal motility within 6 months prior to enrollment.
  • (2) An infection that is active.
  • (3) Combined with irritable bowel syndrome, inflammatory bowel disease, celiac disease, and other chronic gastrointestinal diseases, the condition has not been controlled.
  • (4) Chronic diseases such as cerebrovascular disease, cardiovascular disease, and diabetic autonomic neuropathy.
  • (5) Pregnancy or with a pregnancy plan
  • (6) severe organ dysfunction (including decompensated cirrhosis, malignant tumors, etc.)

Key Trial Info

Start Date :

August 25 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 10 2020

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT04124211

Start Date

August 25 2019

End Date

March 10 2020

Last Update

October 11 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The third affiliated hospital of Southern Medical University

Guangzhou, Guangdong, China, 510630